PBRM1: A Protein Potential Drug Target and Biomarker (G55193)

Target Name: PBRM1

NCBI ID: G55193

PBRM1

PBRM1: A Protein Potential Drug Target and Biomarker

Phosphatidylinositol (PIP) is a crucial signaling molecule in various biological processes that play a vital role in cell signaling, including the regulation of cell adhesion, migration, and invasion. PIP is a phospholipid that is synthesized in the cytosol of cells and is involved in various cellular processes, including the regulation of cell signaling pathways. One of the most well-known PIPs is PBRM1 (OTTHUMP00000202148), which is a protein that is expressed in various tissues and cells in the human body.

PBRM1 function and localization

PBRM1 is a protein that is characterized by its ability to interact with various signaling molecules, including tyrosine and chemokines. It is highly expressed in various tissues, including the brain, heart, and gastrointestinal tract, and has been shown to play a role in various biological processes, including cell signaling, inflammation, and the regulation of cell adhesion.

PBRM1 is a cytoplasmic protein and is primarily localized to the cytosol of cells. It is involved in the regulation of various cellular processes, including the regulation of cell signaling pathways, the regulation of cytoskeletal structure and dynamics, and the regulation of cell adhesion. PBRM1 has been shown to interact with various signaling molecules, including tyrosine, which is a chemical that can interact with PBRM1 and trigger signaling pathways.

PBRM1 as a drug target

PBRM1 is a protein that has potential as a drug target. Its ability to interact with various signaling molecules makes it an attractive target for small molecule inhibitors, including inhibitors that can inhibit tyrosine signaling pathways. PBRM1 has been shown to play a role in various signaling pathways, including the regulation of cell adhesion and the regulation of cell signaling pathways. By inhibiting PBRM1, researchers may be able to reduce the activity of various signaling pathways and improve the regulation of cellular processes.

PBRM1 as a biomarker

PBRM1 has also been shown to be a useful biomarker for various diseases, including cancer. Its ability to interact with various signaling molecules makes it an attractive target for diagnostic tests that can detect changes in the expression of PBRM1. For example, researchers have used PBRM1 as a biomarker to detect various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. By detecting changes in the expression of PBRM1, researchers may be able to diagnose and monitor these diseases.

Conclusion

PBRM1 is a protein that is characterized by its ability to interact with various signaling molecules and its role in various cellular processes. Its potential as a drug target and biomarker make it an attractive target for researchers who are interested in understanding the role of PBRM1 in various biological processes. Further research is needed to fully understand the role of PBRM1 in cellular processes and its potential as a drug target and biomarker.

Protein Name: Polybromo 1

Functions: Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Required for the stability of the SWI/SNF chromatin remodeling complex SWI/SNF-B (PBAF). Acts as a negative regulator of cell proliferation

The "PBRM1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PBRM1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets